Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms 11C-ML03, ML-03 (Hebrew University) |
Target |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | IL | 12 Jul 2005 |